Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | NEU1 | Q99519 | 2/20 | 0.38 |
| ▸ | SELL | P14151 | 1/20 | 0.36 |
| ▸ | SELP | P16109 | 1/20 | 0.36 |
| ▸ | MAG | P20916 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29632786 | 1.00 | NANP (0.67) | NANPL3MBTL1NEU1SELLSELP | |
| SCHEMBL20190565 | 1.00 | NANP (0.67) | NANPL3MBTL1NEU1SELLSELP | |
| SCHEMBL29390472 | 1.00 | NANP (0.67) | NANPL3MBTL1NEU1SELLSELP | |
| SCHEMBL13190787 | 1.00 | NANP (0.67) | NANPL3MBTL1NEU1SELLSELP | |
| SCHEMBL6046356 | 0.91 | NANP (0.62) | NANPL3MBTL1SELLSELPMAG | |
| SCHEMBL28733258 | 0.91 | NANP (0.62) | NANPL3MBTL1SELLSELPMAG | |
| SCHEMBL29462899 | 0.91 | NANP (0.62) | NANPL3MBTL1SELLSELPMAG | |
| SCHEMBL8662575 | 0.91 | NANP (0.65) | NANPL3MBTL1NEU1SELLSELP | |
| SCHEMBL27909377 | 0.91 | NANP (0.65) | NANPL3MBTL1NEU1SELLSELP | |
| SCHEMBL13191004 | 0.90 | NANP (0.56) | NANPL3MBTL1MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4742899-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | claimed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| EP-4662224-A1 | PRODUCTION OF A SACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF LACTOBIONIC ACID | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| EP-4651963-A1 | PURIFICATION OF AN OLIGOSACCHARIDE OR OLIGOSACCHARIDE MIXTURE | Inbiose N.V. (BE) | 2025-11-26 | — | — | EP | claimed |
| WO-2025224348-A1 | PRODUCTION OF A MILK OLIGOSACCHARIDE MIXTURE | INBIOSE N.V. (BE) | 2025-10-30 | — | — | WO | claimed |
| EP-4608849-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | Inbiose N.V. (BE) | 2025-09-03 | — | — | EP | claimed |
| US-12344875-B2 | Sialyltransferases for the production of sialylated oligosaccharides | INBIOSE N.V. (BE) | 2025-07-01 | — | — | US | claimed |
| WO-2025087575-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | INBIOSE N.V. (BE) | 2025-05-01 | — | — | WO | claimed |
| WO-2025088103-A1 | PRODUCTION OF A SIALYLATED COMPOUND | INBIOSE N.V. (BE) | 2025-05-01 | — | — | WO | claimed |
| EP-1032420-A1 | IMMUNOGLOBULIN MOLECULES HAVING A SYNTHETIC VARIABLE REGION AND MODIFIED SPECIFICITY | Euro-Celtique S.A. (BM) | 2000-09-06 | — | — | EP | claimed |
| EP-1030684-A1 | MODIFIED ANTIBODIES WITH ENHANCED ABILITY TO ELICIT AN ANTI-IDIOTYPE RESPONSE | Euro-Celtique S.A. (BM) | 2000-08-30 | — | — | EP | claimed |
| WO-1999025378-A9 | IMMUNOGLOBULIN MOLECULES HAVING A SYNTHETIC VARIABLE REGION AND MODIFIED SPECIFICITY | EURO CELTIQUE SA (US) | 1999-08-12 | — | — | WO | claimed |
| WO-1999025378-A1 | IMMUNOGLOBULIN MOLECULES HAVING A SYNTHETIC VARIABLE REGION AND MODIFIED SPECIFICITY | EURO-CELTIQUE, S.A. (BM) | 1999-05-27 | — | — | WO | claimed |
| WO-1999025379-A1 | MODIFIED ANTIBODIES WITH ENHANCED ABILITY TO ELICIT AN ANTI-IDIOTYPE RESPONSE | EURO-CELTIQUE, S.A. (BM) | 1999-05-27 | — | — | WO | claimed |
| US-5846748-A | Method for diagnosing visceral leishmaniasis in a patient by identification of a new key marker namely 9-O-acetylated sialoglycoconjugate | THE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1998-12-08 | — | — | US | claimed |
| US-5766887-A | Synthesis of 9-0-acetyl N-acetylneuraminic acid oligosaccharides | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-06-16 | — | — | US | claimed |
| EP-0524143-B1 | Process of preparation of activated sialic acids | CIBA GEIGY AG (CH) | 1997-12-10 | — | — | EP | claimed |
| US-5334514-A | Reacting sialic acid with cytidine 5*-triphosphate in presence of cell extract of microorganism having cytidine 5*-monophospho-N-acetylneuraminic acid synthetase activity | CIBA VISION CORPORATION | 1994-08-02 | — | — | US | claimed |
| EP-0524143-A1 | Process of preparation of activated sialic acids | CIBA-GEIGY AG (CH) | 1993-01-20 | — | — | EP | claimed |